Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders – Memorial Sloan Kettering Cancer Center (blog)
Memorial Sloan Kettering Cancer Center (blog) |
Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders
Memorial Sloan Kettering Cancer Center (blog) Some patients who receive immunotherapy drugs called checkpoint inhibitors experience significant benefit in terms of tumor shrinkage and longer survival — but many do not. A new study suggests that measuring changes in the blood could help doctors … Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy? Long term benefits of immunotherapy emerging for some patients, though key questions remain Matching tumor size to strength of immune response allows melanoma drug tailoring |
